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Abstract 
The study reports an advance in designing copper-based redox sensing MRI contrast 
agents. Although the data demonstrate that copper(II) complexes are not able to compete with 
lanthanoids species in terms of contrast, the redox-dependent switch between diamagnetic 
copper(I) and paramagnetic copper(II) yields a novel redox-sensitive contrast moiety with 
potential for reversibility. 
 
Introduction  
 MRI contrast agents capable of detecting redox status in biological tissues would be 
valuable in the diagnosis of  inflammatory diseases that involve an oxidative pathology, such 
as atherosclerosis or rheumatoid arthritis (Filippin et al. 2008; Profumo et al. 2011). 
Historically, contrast agents have depended on lanthanide chemistry (De Leon-Rodriguez et 
al. 2009; Aime et al. 2009) and the development of agents for MRI continues to focus largely 
on gadolinium owing to its key qualities; i.e. it is a quadrupolar nucleus, it has a large number 
of unpaired electrons and when coordinatively unsaturated it displays rapid exchange kinetics 
in aqueous solution (Table 1). However, the synthesis of new, smart imaging agents for 
measuring biochemical processes (e.g. pH and pO2) requires that the contrast agent has added 
capability (Angelovski et al. 2008; Iwaki et al. 2012; Viger et al. 2013; Vologdin et al. 2013) 
A method of introducing added capability is to modify the ligand that chelates the lanthanoid 
centre (Angelovski et al. 2008; Iwaki et al. 2012; Vologdin et al. 2013).  Alternatively, it is 
possible to encapsulate a gadolinium species into a polymer matrix which degrades in 
response to the biological environment (Viger et al. 2013). 
 
- Table 1 in here- 
 
 Recent concerns about the nephrotoxicity of gadolinium suggest that there would be 
advantages in broadening the range of metals used as contrast agents (Badero et al. 2008; 
Ledneva et al. 2009).  The clinical use of transition metals in MRI has been mostly restricted 
to nanoparticles which, as large multimetallic assemblies, are able to compensate for the weak 
relaxivity of the parent elements (e.g. iron, copper) (Di Marco et al. 2007; Longmire et al. 
2008; Kueny-Stotz et al. 2012; Min et al. 2012).  One strategy is to design modified low T2 
nano-particles which assemble in the presence of key biomarkers (e.g. streptavidin-biotin) to 
form assemblies with a high T2 (Min et al. 2012).   
 Certain transition metals (Table 1) have physical properties compatible with their 
development as contrast agents (Tobe 1972; Weast 1980; Grant et al. 1997; Lejeune 1999; 
Yam & Lo 1999; Dorazio & Morrow 2012; Drahos et al. 2012; Thunus & Yu 2012; Loving et 
al. 2013; Gale et al. 2014; Tsitovich et al. 2014).  Since transition metals display different 
coordination chemistry to gadolinium (lower coordination numbers, simpler topologies) and 
can combine with a wider range of ligand types (e.g. phosphines, thiolates), it should be easier 
to target them to physiological parameters such as pH and redox status.  
Due to its large number of unpaired electrons, manganese(II) has attracted the most 
attention as an alternative to gadolinium (Grant et al. 1997; Thunus & Lejeune 1999; Yam & 
Lo 1999; Yu et al. 2012; Loving et al. 2013; Gale et al. 2014).  Indeed, there has been some 
success with manganese in the design of redox sensing contrast agents (Loving et al. 2013; 
Gale et al. 2014; Tsitovich et al. 2014).  Copper(II) also has some attractive properties (Table 
1) (Tobe 1972; Weast 1980).  Although it only has one unpaired electron, its ligand exchange 
rate is higher by two orders of magnitude than manganese and commensurate with that of 
gadolinium (table 1). Furthermore, its chemistry suggests that it should be easier to create an 
available coordination site for water without the risk of forming insoluble oxides (c.f. MnO2, 
Mn2O3). Another advantage of copper over manganese is the availability of a diamagnetic 
form, d10 Cu(I), which can be sustained under biological conditions. The availability of 
diamagnetic (Cu(I)) and paramagnetic (Cu(II)) forms allows the design of agents that have 
redox switch capability. Lauffer briefly discussed the properties of copper as a platform for 
the design of imaging agents 25 years ago, deeming it unsuitable for use due to its poor 
relaxivity (Lauffer 1987).  However, the advent of better imaging software, access to higher 
field strengths, more sophisticated pulse sequences and the emergence of chemical exchange 
saturation transfer (CEST) as a relaxation mechanism, the need for metals with such high 
relaxivity may be coming to an end (De Leon-Rodriguez et al. 2009; Aime et al. 2009; Hancu 
et al 2010; Sherry & Wu 2013). The design of MRI contrast agents has developed 
significantly over the past 25 years and it is not uncommon for discrete sensing moieties to be 
attached directly to a MRI reporting gadolinium species.  Thus, should copper remain an 
unsuitable metal in its own right, there are opportunities to bolster its poor relaxivity by 
combining a reporting copper complex with a more responsive gadolinium species. Although 
the relaxivity of copper will never supersede that of manganese or gadolinium, its potential as 
a switchable redox sensing contrast moiety makes it an interesting target and, considering all 
the advances in the field of MRI over the past 25 years, a topic worth re-visiting.   
 
Experimental 
 Unless otherwise stated, all chemicals were commercially obtained and used 
without further purification. Gd(DTPA) and Cu(BF4)2 were purchased from the Sigma-
Aldrich company UK. SprNen and the unmodified copper macrocycles ([Cu(II)SenNen]2+, 
[Cu(II)SenNpr]2+, [Cu(II)SprNen]2+ and [Cu(II)SprNpr]2+) were prepared as previously 
reported (Taylor et al. 2008; Trotter et al. 2009; Trotter et al. 2010; Sowden et al. 2013).  
Solid reflectance spectra (400 – 900 nm) were recorded on a Photonics CCD array UV-
Vis spectrophotometer.  Electrospray mass spectra were recorded using a Thermo 
Finnigan LCQDuo instrument equipped with anion trap as described previously (Taylor 
et al. 2008; Trotter et al. 2009; Trotter et al. 2010; Sowden et al 2013). The 
spectrophotometric titrations were carried out on a Unicam UV 300 spectrometer. 
 
X-Ray crystallography: Crystals were coated in mineral oil and mounted on glass 
fibres.  Data were collected at 123 K on a Nonius Kappa CCD diffractometer using 
graphite monochromated Mo-KD radiation.  The heavy atom positions were determined 
by Patterson methods and the remaining atoms located in the difference electron density 
maps.  Full matrix least squares refinement was based on F2 with all non-hydrogen atoms 
anisotropic.  While the hydrogen atoms were mostly observed in the difference maps, 
they were placed in calculated positions riding on the parent atoms.  The structure 
solution and refinement used the programs SHELX-97 and the graphical interface 
WinGX (Sheldrick 1998; Farrugia 1999) 
 
Preparation of N-substituted macrocycles: SprNen (1.04 g, 0.003 mol) was dissolved 
in acetonitrile (100 mL) to which sodium bicarbonate (5.07g, 0.06 mol) was added. 
The mixture was stirred and heated to reflux. Halo-alkane (2-bromo-ethanol, 3-bromo-
propan-1-ol or bromoacetic acid, 2 mol equiv.) in acetonitrile (50 mL) was added drop-
wise to the refluxing mixture over a 6 hr period.  The mixture was then refluxed 
overnight. The solution was left to cool, before being filtered. The solvent was 
removed in vacuo, resulting in a yellow waxy solid.  The products were used as 
received. Yields were typically in the order of 70%.  
 
cis-SprNen(-(CH2)2OH)2: Mass Spec. (ESI) m/z 455.27 [M+Na]+.  
cis-SprNen(-(CH2)3OH)2: Mass Spec. (ESI)  m/z 461.14 [M+H]+.  
cis-SprNen(-CH2COOH)2: Mass Spec. (ESI)  m/z 461.13 [M+H]+. 
 
Preparation of N-substituted copper(II) macrocycles:  The required N-substituted 
macrocycle (1.04 g) was dissolved in methanol (150 mL) and treated with an 
equimolar amount of Cu(BF4)2.6H2O (0.96 g) dissolved in methanol (10 mL). An 
immediate colour change from pale yellow to dark green was observed.  The resulting 
solution was refluxed gently overnight. The solution was cooled and filtered and the 
solvent removed in vacuo to yield a dark green solid. The crude product was re-
dissolved in the minimum amount of methanol, filtered through celite and 
recrystallised by vapour diffusion using diethyl ether to give a dark green powder.  
 
cis-[Cu(II)SprNen(-(CH2)2OH)2] 2BF4: Anal. Calcd. for C23H32 N2S2O2CuB2F8: C, 
39.30; H, 4.41; N, 4.36 % Found: C, 39.98; H, 4.72; N, 4.57 %. Mass Spec (ESI) m/z 
495.08 [M]+, 451.13 [M-CH2CH2O]+.  Omax (solid reflectance) 435 nm, 640 nm. 
cis-[Cu(II)SprNen(-(CH2)3OH)2] 2BF4: Anal. Calcd. for C25H36 N2S2O2CuB2F8: C, 
43.04; H, 5.16; N, 4.02 %  Found: C, 43.83; H, 5.46; N, 3.98 %. Mass Spec (ESI) m/z 
523.20 [M]+, Omax (solid reflectance) 435 nm, 600 nm.  XRD data: Monoclinic C2/c, a 
= 35.7398(14) Å, b = 9.1810(3) Å, c = 21.0854(7) Å, E = 92.385(3)o, V (Å3) 
6912.7(4), Z = 8, robs = 0.0438, wR2 = 0.1104.  
cis-[Cu(II)SprNen(-CH2COOH)2] 2BF4: Anal. Calcd. for C23H28 N2S2O4CuB2F8: C, 
41.94; H, 4.44; N, 3.86 % Found: C, 42.13; H, 4.42; N, 4.02 %.  Mass Spec (ESI) m/z 
523.27 [M]+. Omax (solid reflectance) 415 nm, 600 nm. 
cis-[Cu(II)SprNen(-(CH2)2SPh)2] 2BF4: Anal. Calcd. for C35H40 N2S4CuB2F8: C, 
49.22; H, 4.68; N, 3.28 % Found: C, 49.67; H, 4.79; N, 3.11 %. Mass Spec (ESI) m/z 
679 [M]+, 543 [M-C9H12S]+ Omax (solid reflectance) 425 nm, 610 nm.  
 Preparation of [Cu(II)SprNphenR]2+ 2BF4-: 5-nitro-2-chloro-benzaldehyde (1.86 g, 
0.01 mol) was dissolved in iso-propylalcohol to which o-phenylenediamine (0.6 g, 
0.005 mol) was added.  The solution was stirred at room temperature for an hour and a 
yellow precipitate formed. The solution was then filtered and the Schiff base, as a 
yellow solid, collected and dried. 
 
1+1050+]'062į+V+-CH=N-), 8.92 (d, 2H, arom), 8.29 (dd, 
4H, arom), 7.87 (d, 2H, arom), 7.17 (d, 2H, arom), Anal. Calcd. for C20H12Cl2N4O4: 
C, 54.20; H, 2.73; N, 12.64 % Found: C, 54.34; H, 2.60; N, 12.83 % Mass Spec. (ESI) 
m/z 443 [M+H]+  
 
 The Schiff base (10 mmol) was dissolved in dichloromethane to which 
Cu(BF4)2 (0.34 g, 10 mmol) was added. The compound was heated to reflux and then 
propanedithiol (0.09g, 5 mmol) added drop-wise.  The solution was subsequently 
refluxed for 48 hours. The solution was then filtered and the solvent removed in vacuo 
to yield a green-black oil. The crude product was dissolved in distilled water and 
extracted with dichloromethane and dried over anhydrous sodium sulphate.  The 
solvent was removed to yield the copper Schiff base macrocycle as a green-black oil.  
 
Anal. Calcd. for C23H18N4O4S2CuB2F8: C, 38.60; H, 2.53; N, 7.83 % Found: C, 
40.98; H, 2.60; N, 6.59 % Mass Spec. (ESI) m/z 541 [M]+   
 
 The Schiff base macrocyclic complex (10 mmol) was dissolved in ethanol (100 
ml) and an excess of NaBH4 (1 g) was added portionwise to the solution and stirred 
overnight. The excess NaBH4 was quenched with ammonium acetate. The solvent was 
then removed in vacuo to yield a green oil.  This was dissolved in distilled water and 
extracted with dichloromethane and dried over anhydrous sodium sulphate.  The 
solvent was removed in vacuo to yield [Cu(II)SprNphenR]2+ 2BF4- as a green solid.  
 
Anal. Calcd. for C23H20N4O4S2CuB2F8: C, 38.37; H, 4.42; N, 7.67 % Found: C, 
39.03; H, 4.26; N, 7.59 %. Mass Spec. (ESI) m/z 543 [M]+.  Omax (solid reflectance) 
425 nm, 610 nm. 
 
Relaxation measurements:  Relaxation measurements were carried out in triplicate on 
a Bruker Avance I NMR spectrometer equipped with an 11.7 T magnet. The 
measurements were carried out using an inversion recovery pulse sequence under full 
automation control with a 90º pulse width of 11.5 µs.  All spectra were referenced 
internally to the residual proton resonance of the relevant deuterated solvent.  The 
relaxation delay was varied from 1-100 s, depending on the relaxation characteristics 
of the sample.  Data were transferred for remote data processing using Topspin 
(version 2.1, Bruker Biospin, Karlsruhe) on a desktop PC running under Windows XP. 
Following Fourier transformation, all data were baseline corrected. The T1/T2 sub-
routine within Topspin was used to evaluate the relevant T1 values from the data. 
 Samples of the copper macrocycles, GdDTPA and Cu(BF4)2 were prepared in 
0.1 M NaCl, 100% D2O in a 10 mL volumetric flask at concentrations of 10 mM, 2.5 
mM, 1 mM, 0.1 mM and 0.01 mM.  A control sample of 0.1 mM NaCl in 100% D2O 
was also included.   
 
Electrochemistry: Cyclic voltammetry in aqueous solution was carried out on a CH 
Instruments 660A Electrochemical Workstation with iR compensation, using ultra high 
purity water (Elga: 0.22PP ILOWHUHG  0ȍFP DQG DFHWRQLWULOH UHGLVWLOOHG IURP
calcium hydride).  The electrodes were glassy carbon, platinum wire and silver wire as 
the working, counter and reference electrodes, respectively. All solutions were 
degassed with argon and contained sample concentrations 2 x 10-3 M for acetonitrile, 
together with the supporting electrolyte; tBu4NBF4 (0.1 M) respectively.  
Measurements are referenced against the redox couple (E½) of ferrocene / ferrocenium. 
 
Chemical redox cycling: Reduction: A solution of the copper macrocyclic (0.3 mM) 
complex and reducing agent (10 mM ascorbic acid) was prepared in Tris-buffer (5 mM 
pH 7.4). A 1.0 ml volume of the solution of the complexes was placed in a 1.5 ml 
quartz cuvette (1 cm pathlength) and the spectrum was recorded (250-800 nm).  The 
solution was titrated with reducing agent in 5 Pl aliquots. The cuvette was allowed to 
stand for 5 minutes at room temperature to allow the solution to come to equilibrium 
before the spectrum was recorded. The titrations continued until no further change was 
observed. Each experiment was carried out in triplicate.  
 Re-oxidation: A solution of the copper macrocyclic complex (0.3 mM) was 
prepared in Tris-buffer (5 mM, pH 7.4) and reduced using ascorbic acid from the data 
above to generate the copper (I) complex in-situ. A 1.0 ml volume of the solution  of 
the required copper complexes was placed in a 1.5 ml quartz cuvette (1 cm pathlength) 
and the spectrum was recorded (250 - 800 nm) against a Tris-buffer reference placed in 
a matched cuvette. A 100 mM solution of sodium hypochlorite was titrated in 5 Pl 
aliquots into the solution. The cuvette was allowed to stand for 5 minutes at room 
temperature to allow the solution to come to equilibrium before the spectrum was 
recorded. The titrations continued until no further change was observed in the spectra. 
Each experiment was carried out in triplicate.  
 
Results and Discussion 
 As a potential platform for the design of copper-based MRI moieties, we have 
synthesized and studied three related series of copper complexes (Taylor et al. 2008; 
Trotter et al. 2009; Trotter et al. 2010; Sowden et al 2013). The first series (Figure. 1) 
comprise four thioether-secondary amine macrocycles where the alkyl chains linking 
the donor atoms are modified so as to allow the formation of 14, 15 or 16 membered 
rings. In all of these complexes the macrocycle lies in the meridial plane of the metal. 
A number of these complexes crystallise with a solvent molecule (MeCN, H2O) 
coordinated to the copper atom in an axial position (Taylor et al. 2008; Trotter et al. 
2009. This structural feature indicates that a relaxation mechanism similar to that found 
in Gd(DTPA) should be available with these copper macrocycles.  A second series of 
macrocycles contain tertiary amines have been prepared.  Here the pendant arms (X in 
Figure 1) include a terminal donor atom, which is introduced to increased the denticity 
of the ligand and the stability of the resulting copper complex.  A third system has 
been synthesised that includes electron withdrawing groups (Figure 1, aryl and -NO2) 
in an attempt to support the copper(I) form better.  
 
-Figure 1 in here- 
 
 The secondary amine copper macrocycles (figure 1 left) were prepared as 
previously described (Sowden et al 2013) and their relaxation properties assessed in 
saline solution (0.10 M NaCl, 2H2O, 9.4T).  The performance of the species were 
measured against Gd(DTPA) and Cu(BF4)2. Gd(DTPA) was included as a reference 
material to demonstrate the relative ability of these copper macrocycles to act as 
contrast agents. A simple hydrated copper salt (Cu(BF4)2) was also included in the 
study to gauge the maximum effect one might expect from copper agents and in turn 
the influence of the macrocyclic ligand. As expected, the relaxation measurements 
(Table 2) show that hydrated copper(II) ions have poor relaxivity compared to 
gadolinium (Lauffer 1987).  The hydrated copper(II) cation has a primary coordination 
sphere of six waters and a weakly bound secondary coordination sphere of up to eight 
water molecules (Persson 2010).  Consequently, it is unsurprising that once the copper 
is placed within the macrocycles four of the exchange sites are occupied and the 
relaxivity falls. 
 
- Table 2 in here- 
 
It has been shown previously that bovine serum albumin (BSA) can efficiently 
remove the copper from these secondary amine macrocycles (Figure 1, top left) in 
competitive binding studies (Sowden et al 2013). Thus, although the copper macrocycles 
have the potential to act as contrast agents, in order to have any real utility the stability of 
these complexes needs to be increased. Earlier studies have shown that the 
[Cu(II)SprNen]2+ motif was marginally more resistant to de-metalation by BSA and this 
framework was adopted for modification (Sowden et al 2013).  Preliminary studies using 
a tertiary amine complex that incorporates ethanol pendant arms (Figure 1 top right, X = -
(CH2)2OH) indicated that this modification prevented BSA from removing the metal 
from the complex (Sowden et al 2013).  Mattes et al. have previously synthesised a range 
of macrocyclic species based on [Cu(II)SenNen]2+ and [Cu(II)-SenNpr]2+) that have 
ethanol, acetate and pyridyl groups attached to the secondary amines (Funkemeier & 
Mattes 1993; Bentfeld et al. 1995; Mattes et al. 2004).  In the solid state, these complexes 
are observed to be cationic, five coordinate species in which the pendant donor oxygen 
atoms are in the coordination sphere of the copper, lie cis- to one another and are found in 
their protonated form. The two donor oxygen atoms are included in the coordination 
geometry at the expense of one of the ring sufur atoms. The [Cu(II)SprNen]2+ platform has 
good potential and we have therefore adapted the work of Mattes et al. to introduce 
ethanol, propanol, acetate and arylthioether pendant arms into this motif (Figure. 1). 
Although all four complexes were isolated and characterised, only [Cu(II)SprNen(-
(CH2)3OH)2]2+ provided X-ray quality crystals. In contrast to the structures reported 
previously, this complex was found to adopt a five coordinate square based pyramidal 
structure (Figure 2). Although both alcohol groups are found above the plane of the 
ligand and are protonated, only one of the hydroxyl groups coordinates. The structures of 
the corresponding ethanol, acetate thioether adducts remain unclear at this time but we 
would predict that they are also five coordinate in the solid state (Funkemeier & Mattes 
1993; Bentfeld et al. 1995; Mattes et al. 2004).   
 
-Figure 2 in here- 
 
 The fifth donor atom was introduced into the ligand to increases the stability of 
the complexes.  Typically the stability of a complex is framed using its formation 
constants, which are then used to hypothesise about the potential biochemistry.  We 
have developed a more direct method of analysis whereby the copper complex is 
titrated with BSA (Sowden et al 2013).  Using this approach, we circumvented the 
need to calculate each individual formation constant and directly observed if the 
protein can sequester the metal (copper). Using this approach we can show that copper 
in the five coordinate species are stable to metal sequestration by BSA.†  Although the 
introduction of a fifth donor into the motif has generated a suite of complexes that are 
suitably bio-tolerant, the increase in stability requires that a fifth water exchange site 
(c.f. Cu(BF4)2) is occupied and consequently the relaxivity of the complexes falls 
(Table 2).   
 The ability of the compounds to act as redox sensing contrast agents requires 
that they have redox reversibility between the copper(II) and copper(I) forms. The 
issue of redox reversibility has been interrogated in two ways: electrochemically and 
chemically.  Electrochemical analysis of the compounds (Table 1) shows that the 
addition of the pendant arms has raised the E0 of the complexes significantly.  
Surprisingly, the addition of electron withdrawing groups (i.e. [Cu(II)SprNphenR]2+) and 
soft donor moieties ([Cu(II)SprNen((-CH2)2SPh)2]2+) into the motif has little impact on 
redox potential of the copper centre and the values obtained for these species (1.2-1.5 
V) consistently come to the higher end of the desired range (table 2). The 
voltammograms of compounds indicate that the addition of pendant arm donor 
moieties renders the complexes irreversible except in one case i.e. ([Cu(II)SprNen((-
CH2)2SPh)2]2+).  This compound shows good reversibility at a range of scan rates 
(Figure 3.).  This indicates that an increase in the sulphur density around the copper 
centre is having a beneficial effect and that the additional soft donors is able to support 
the formation of the copper(I) species during redox cycling better.   
 
- Figure 3 in here- 
-figure 4 in here- 
 
 In our previous studies we investigated the redox chemistry of our compounds 
by subjecting them to chemical redox cycling using ascorbic acid reduction followed 
by hypochlorite oxidation (Taylor et al. 2008; Trotter et al. 2009; Trotter et al. 2010; 
Sowden et al 2013).  Repeating this approach here, we found behaviour which 
paralleled the electrochemical study above.  While all the compounds could be 
stoichiometrically reduced, only [Cu(II)SprNen((CH2)2SPh)2]2+ could be efficiently re-
oxidised (~85%) back to the divalent state (Fig 4.). The ability to re-oxidise 
[Cu(II)SprNen((CH2)2SPh)2]2+ is a significant improvement over the previous 
compounds studied (table 1) (Taylor et al. 2008; Trotter et al. 2009; Trotter et al. 2010; 
Sowden et al 2013).  However, whereas reduction remains stoichiometric, re-oxidation 
still required an excess of oxidant to effect the redox switch.  
 
Conclusions 
 Here we present the first major effort to explore copper’s ability to be used as a 
redox-sensitive MRI moiety.  As predicted by Lauffer (1987), the relaxivity of these 
copper based species is poor compared with gadolinium and considerable further 
development is needed before copper will be able to perform independently as a redox 
sensitive contrast agent. The study does indicate that it should be possible to generate a 
compound which is stable in both the +1 and +2 oxidation states under biological 
conditions with an appropriate oxidation potential.  However, it is clear that for these 
compounds to have any use in MRI they will have to be coupled with a higher 
relaxivity metal such as gadolinium.  Finally, it would be better if the sensing agent 
was administered in its low valent form and the challenge now is to produce copper(I) 
complexes of this type that respond to oxidants rather than copper(II) complexes which 
respond to reductants.  
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Electronic Supplementary Information (ESI) available:  
 Details of the X-ray crystal structure determination of [Cu(II)SprNen(-
(CH2)3OH)2] 2BF4 may be obtained from the CCDC; e-mail deposit@ccdc.cam.ac.uk 
or www:http://ccdc. cam.ac.uk) on request quoting the depository numbers ccdc 
953160.  †The supporting information contains details on the competitive binding 
studies of the macrocycles with BSA. 
 
Notes and references 
 It should be noted that Kupka et al. (1992) made a brief comment on the 
potential use of copper(II) D-penicillamine as a contrast agent in plants.  To our 
knowledge this work did not develop further. 
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Table Captions 
Table 1. The properties of gadolinium and certain first row transition metal species key to 
their ability to perform as contrast agents (Tobe 1972, Handbook of Chemistry 1980).  Unlike 
the lanthanoids, the exchange kinetics and number of unpaired electrons vary more widely 
and are governed by the prevailing oxidation state and ligand field considerations. Oh denotes 
an octahedral geometry 
 
Table 2. Relaxivity and electrochemical data: The relaxivity of GdDTPA, Cu(BF4)2, 
[Cu(II)SenNen]2+; [Cu(II)SprNen]2+; [Cu(II)SenNpr]2+;[Cu(II)SprNpr]2+; [Cu(II)SprNen(X)2]2+, 
where X = -(CH2)2OH, -(CH2)3OH, -CH2COOH, -(CH2)2SPh and [Cu(II)SprNphenR]2+ (n = 
3) in 0.1 M NaCl in 2H2O at 9.4T.  . Electrochemical data for the copper macrocycles in 
acetonitrile (0.1M tBu4NBF4: The values for the complexes are expressed relative to the 
normal hydrogen electrode (HNE) (Taylor et al. 2008) 
 
Figure Captions 
Figure 1 The copper macrocyclic frameworks studied (Taylor et al. 2008; Trotter et al. 2009; 
Trotter et al. 2010; Sowden et al. 2013).  (a) Secondary amine complexes, where the 
polymethylene chains between the nitrogen and sulfur donor atoms are ethylene (en) or 
propylene (pr) giving rise to four compounds: [Cu(II)SenNen]2+, [Cu(II)SenNpr]2+, 
[Cu(II)SprNen]2+ and [Cu(II)SprNpr]2+. (b) Tertiary amine complexes [Cu(II)SprNen(X)2]2+, 
where X = -(CH2)2OH, -(CH2)3OH, -CH2COOH or –(CH2)2SPh.  (c) [Cu(II)SprNphenR]2+ 
where additional electron withdrawing groups (aryl, -NO2) are included in the motif. 
 Figure 2.  The X-ray crystal structure of [Cu(II)SprNen(-(CH2)3OH)2]2+.  The counter ions 
(BF4-) are omitted for clarity.  The copper sits in a distorted square based pyramidal 
geometry. The hydrogens on the oxygens were found during refinement.  The thermal 
ellipsoids are shown at 50% probability. Selected metrical parameters (d/Å, o) Cu-S 
2.3450(7), 2.3487(7); Cu-N 2.045(2), 2.052(2); Cu-O 2.1725(18); <S-Cu-N (o), 163.00(6), 
93.48(6), 176.82(6), 93.49(6).  
 
Figure 3.  The cyclic voltammogramm of [Cu(II)SprNen((CH2)2SPh)2] 2BF4 (2 mM) in 
acetonitrile/tBuNBF4 (0.1M) at scan rates of 10, 40, 80, 120, 160 and 200 mVs-1. The E0 
values (table 2) were referenced to the normal hydrogen electrode using a ferrocene standard.  
 
Figure 4.  The chemical reduction of [Cu(II)SprNen((CH2)2SPh)2]2+ by ascorbic acid (left) 
followed by the chemical re-oxidation using hypochlorite (right).  The figure is a composite 
of the data from two separate titrations. 
Table 1 
 
 
 
 
 
 
 
Table 1. The properties of gadolinium and certain first row transition metal species 
key to their ability to perform as contrast agents (Tobe 1972, Handbook of Chemistry 
1980).  Unlike the lanthanoids, the exchange kinetics and number of unpaired 
electrons vary more widely and are governed by the prevailing oxidation state and 
ligand field considerations. Oh denotes an octahedral geometry 
 
 No. unpaired electrons and 
relevant oxidation state 
Nuclear spin 
(abundance %) 
Exchange rate 
(s-1) 
Gd 7 3/2 155Gd (14.7) 
3/2 157Gd   (15.7) 
109  
V 2  (III) 7/2 51V   (99.8) 103 
Cr 4  (II) 
3  (III) 
3/2 53Cr   (9.6) 109       
5 x 10-5 
Mn 7  (II) 5/2 55Mn   (100) 5 x 107 
Co 3  (II)  high spin Oh 
0  (III) low spin Oh 
7/2 59Co  (100) 5 x 106 
5 x 10-5 
Cu 1  (II) 
0  (I) 
3/2 63Cu   (69.1) 
3/2 65Cu   (30.9) 
109 
Table 2 
 
Relaxivity and electrochemical data: The relaxivity of GdDTPA, Cu(BF4)2, 
[Cu(II)SenNen]2+; [Cu(II)SprNen]2+; [Cu(II)SenNpr]2+;[Cu(II)SprNpr]2+; 
[Cu(II)SprNen(X)2]2+, where X = -(CH2)2OH, -(CH2)3OH, -CH2COOH, -(CH2)2SPh 
and [Cu(II)SprNphenR]2+ (n = 3) in 0.1 M NaCl in 2H2O at 9.4T.  . Electrochemical 
data for the copper macrocycles in acetonitrile (0.1M tBu4NBF4: The values for the 
complexes are expressed relative to the normal hydrogen electrode (HNE). * (Taylor 
2008) 
 Compound Relaxivity s-1mM-1 E0 V 
Reference 
compounds 
Gd(DTPA) 4.73  
CuII(BF4)2 0.67  
Simple macrocycles  
(Fig 1a) 
[Cu(II)SenNpr]2+,  0.27 + 0.03 0.65*c 
[Cu(II)SprNen]2+  0.27 + 0.01 0.85 (57%) 
[Cu(II)SprNpr]2+ 0.26 + 0.03 0.85*c 
Pendant arm 
macrocycles 
[Cu(II)SprNen(X)2]2+ 
(Fig 1b) 
X= -(CH2)2OH 0.42 + 0.02 1.04 (22%) 
X= -(CH2)3OH 0.16 + 0.02 1.23 (21% 
X= -CH2COOH 0.11 + 0.01 1.44 (24%) 
X= -(CH2)2SPh 0.12 + 0.02 1.28 (79%) 
Macrocycle-EWG 
(Fig 1c) 
[Cu(II)SprNphenR]2+ 0.11 + 0.02 1.42 (9%) 
Figure 1. The copper macrocyclic frameworks studied (Taylor et al. 2008; Trotter et al. 2009; Trotter et al. 2010; 
Sowden et al. 2013).  (a) Secondary amine complexes, where the polymethylene chains between the nitrogen 
and sulfur donor atoms are ethylene (en) or propylene (pr) giving rise to four compounds: [Cu(II)SenNen]
2+, 
[Cu(II)SenNpr]
2+, [Cu(II)SprNen]
2+ and [Cu(II)SprNpr]
2+. (b) Tertiary amine complexes [Cu(II)SprNen(X)2]
2+, where X = -
(CH2)2OH, -(CH2)3OH, -CH2COOH or (CH2)2SPh.  (c) [Cu(II)SprNphenR]
2+ where additional electron withdrawing 
groups (aryl, -NO2) are included in the motif. 
Figure 2.  The X-ray crystal structure of [Cu(II)SprNen(-(CH2)3OH)2]
2+.  The counter ions (BF4
-) are omitted for clarity.  
The copper sits in a distorted square based pyramidal geometry. The hydrogens on the oxygens were found 
during refinement.  The thermal ellipsoids are shown at 50% probability. Selected metrical parameters (d/Å, o) 
Cu-S 2.3450(7), 2.3487(7); Cu-N 2.045(2), 2.052(2); Cu-O 2.1725(18); <S-Cu-N (o), 163.00(6), 93.48(6), 176.82(6), 
93.49(6).  
Figure 4.  The chemical reduction of [Cu(II)SprNen((CH2)2SPh)2]
2+ by ascorbic acid (left) followed by the chemical 
re-oxidation using hypochlorite (right).  The figure is a composite of the data from two separate titrations. 
Figure 3.  The cyclic voltammogramm of [Cu(II)SprNen((CH2)2SPh)2]
 2BF4 (2 mM) in acetonitrile/
tBuNBF4 (0.1M) 
at scan rates of 10, 40, 80, 120, 160 and 200 mVs-1. The E0 values (table 2) were referenced to the normal 
hydrogen electrode using a ferrocene standard.  
Copper complexes as a source of redox active MRI contrast agents. 
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Supporting Information 
Competitive binding studies: Rather than measure the formation constants to arrive at 
a value which has limited biological impact, we elected to challenge our copper 
complexes directly with bovine serum albumin (BSA).  This simple experiment is 
designed to probe stability of our copper complexes directly in competition with BSA, 
which is a major metal scavenger  present in the blood stream.  This simple, direct 
experiment more closely models the sequestration of metals in-vivo.    
 
Reaction of the copper(II) complexes with bovine serum albumin (BSA):  0.3 mM 
solutions of each of the copper macrocycles and BSA (199 mg, 1 mL) were prepared in 
Tris-HCl buffer (5 mM, pH 7.4).  A 1.0 mL volume of the solution of each of the 
required copper complexes was placed in a  1.5 mL quartz cuvette (1.0 cm path length) 
and the spectrum was recorded between 200 and 800 nm against a Tris-buffer 
UHIHUHQFHSODFHGLQDPDWFKHGFXYHWWH%6$VROXWLRQZDVWLWUDWHGLQDOLTXRWVRIȝ/
into the cuvette.   
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Figure ESI1: Left: The spectrophotometric titrations (412 nm) of cis-[Cu(II)SprNen]2+ 
(adapted from Sowden et al.) and cis-[Cu(II)SprNen(-(CH2)3OH)2]2+. Right: The 
spectrophotometric titrations (350-800) of cis-[Cu(II)SprNen(-(CH2)3OH)2]2+: (0.3 mM in 5 
mM Tris buffer at pH 7.4) with BSA solution (199 mg, 1 mL).  A small diminution in the 
spectrum of cis-[Cu(II)SprNen(-(CH2)3OH)2]2+ of the absorbance occurs owing to dilution of 
the sample as the titrant is added.  The integrity of the complex (cis-[Cu(II)SprNen(-
(CH2)3OH)2]2+) is maintained throughout and the copper is not being sequestered from the 
ligand cavity. 
Sowden RJ et al (2013) Biometals 26: 85-95. 
